期刊文献+

乳癌哨兵淋巴结检测临床应用 被引量:1

Clinical application of sentinel lymph node biopsy in breast carcinoma
原文传递
导出
摘要 目的:探讨乳癌哨兵淋巴结活检预测腋窝淋巴结转移状态的可靠性.方法:本组为2000年11月至2004年2月我院收治的140例乳癌患者.术中应用国产亚甲蓝注射液4~6 ml肿瘤上、外、下半圆形皮下连续注射,134例行乳癌改良根治术或患侧乳腺区段切除加腋窝淋巴结清扫术.术后解剖蓝染淋巴管,沿着色淋巴管找到蓝染的哨兵淋巴结.哨兵淋巴结及腋窝淋巴结常规行石蜡病理切片检查.5例行乳腺区段切除加哨兵淋巴结活检,1例行全乳切除加哨兵淋巴结活检(冰冻、石蜡病理检查SLN转移阴性),未行全腋窝淋巴结清扫.结果:140例患者中136例检出哨兵淋巴结,检出率97.14%,灵敏度 88.71%,准确率94.31%,阴性预测值89.71%,假阴性率11.29%,仅哨兵淋巴结阳性7例.结论:应用亚甲蓝注射液淋巴结着色方法行乳癌哨兵淋巴结活检可以准确地预测腋窝淋巴结转移状态. Objective:To evaluate feasibility and accuracy of lymphatic mapping of sentinel lymph node biopsy for predicting axillary lymph node status in patients with breast carcinoma. Methods :140 patients with primary breast carcinoma were enrolled. Mapping procedures were performed using methylene blue (4-6 ml) subcutaneous injection above, below and outside around the primary tumor followed by modified radical mastectomy or lumpectomy with axillary lymph node dissection( 134 cases). The blue lymphatic vessels were followed to find the blue sentinel lymph nodes. All the sentinel lymph nodes and axillary lymph nodes were examined by hematoxylin eosin (HE) staining of paraffin section after operation. Six cases were sentinel lymph node metastases negative, examined by intraoperative frozen section and paraffin section HE staining after operation without axillary lymph node dissection. Results: The overall positive rate of sentinel lymph node was 97.14% (116 of 120 cases). The sensitivity was 88.71%, accuracy was 94.31%, negative predictive value was 89. 71% and false negative rate was 11.29%. Seven cases had sentinel lymph node metastases only. Conclusion :The results suggest that the sentinel lymph node biopsy using methylene blue is an accurate predictor of axillary lymph node status in patients with breast carcinoma.
出处 《军事医学科学院院刊》 CSCD 北大核心 2006年第2期159-161,183,共4页 Bulletin of the Academy of Military Medical Sciences
关键词 乳腺肿瘤 哨兵淋巴结 腋窝淋巴结 淋巴转移 breast carcinoma sentinel lymph node axillary lymph node lymphatic metastasis
  • 相关文献

参考文献13

  • 1Rivadeneira DE,Simmons RM,Christos PJ,et al.Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas:analysis in more than 900 patients[J].J Am Coll Surg,2000,191(1):1-6.
  • 2Cabanas RM.An approach for the treatment of penile carcinoma[J].Cancer,1977,39(2):456-466.
  • 3Morton DL,Wen DR,Wong JH,et al.Technical details of intraoperative lymphatic mapping for early stage melanoma[J].Arch Surg,1992,127(4):392-399.
  • 4Krag DN,Weaver DL,Alex JC,et al.Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe[J].Surg Oncol,1993,2(6):335-339.
  • 5Giuliano AE,Jones RC,Brennan M,et al.Sentinel lymphadenectomy in breast cancer[J].J Clin Oncol,1997,15(6):2345-2350.
  • 6O'Hea BJ,Hill AD,EL-Shirbiny AM,et al.Sentinel lymph node biopsy in breast cancer:initial experience at Memorial Sloan-Kettering Cancer Center[J].J Am Coll Surg,1998,186(4):423-427.
  • 7Veronesi U,Paganelli G,Galimberti V,et al.Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes[J].Lancet,1997,349(9069):1864-1867.
  • 8Schrenk P,Rehberger W,Shamiyeh A,et al.Sentinel node biopsy for breast cancer:does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node[J]? J Surg Oncol,2002,80(3):130-136.
  • 9Schrenk P,Hatzl-Griesenhoter M,Shamiyeh A,et al.Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection[J].J Surg Oncol,2001,77(3):165-170.
  • 10Meijer S,Torrenga H,van der Sijp JR.Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases[J].Ned Tijdschr Geneeskd,2002,146(20):942-946.

同被引文献22

  • 1Meijer S, Torrenga H, Van der Sijp JR. Negative sentinel node in breast cancer patients a good indicator for continue absence of axillary metastases. Ned Tijdshr Geneeskd, 2002,146:942-946.
  • 2Taback B, Nguyen P, Hansen N, et al. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol, 2006,13 : 1099-1104.
  • 3Moore KH, Sweeney K J, Wilson ME, et al. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Ann Surg Oncol,2007,14:2911-2917.
  • 4Davit FE, Gatmaitan P, Garguilo G. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community. Am Surg,2008 ,74 :423-427.
  • 5Danforth DN Jr, Findlay PA, McDonald HD, et al. Complete axillary lymph node dissection for stage Ⅰ -Ⅱ carcinoma of the breast. J Clin Oncol, 1986,4:655.
  • 6Fisher B, Montague E, Redmond C, et al. Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome. Cancer, 1980, 46:1-13.
  • 7Fisher B, Wolmark N, Redmond C, et al. Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. Ⅱ. The clinical and biologic significance of medial-central breast cancers. Cancer, 1981,48:1863-1872.
  • 8Rivadenier DE, Simmons RM, Christos PJ, et al. Predictive factors associated with axillary lymph node metastases in Tla and Tlb breast carcinomas: analysis in more than 900 patients. J Am Coll Surg, 2000,191:1-8.
  • 9Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med, 1999,339: 941-946.
  • 10Cabanas R. An approach for the penile carcinoma. Cancer, 1977,39:456-466.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部